Abstract
Aims To estimate the incidence of chronic dialysis in patients with a history of cancer and assess how renal replacement therapy is initiated in this population. Methods We merged data from cancer registries and hospital databases in one French region to identify patients with an incident cancer between 2001 and 2008 who started chronic dialysis. Results Mean participation time was 3.4 ± 2.7 years. Males comprised 58.5 % of participants. During the study period, 74 chronic dialysis treatments were initiated. Chronic interstitial nephritis was the leading cause of end-stage renal disease (21.6 %), and 46.6 % of dialysis initiation cases were unplanned. The incidence rate of chronic dialysis initiation in the population of incident cancer patients was 370 per million population/year (74 events/199,809 person-years). After age-adjustment, the standardized incidence ratio was 1.26, 95 % confidence interval 0.98–1.57, p = 0.55. Conclusion Cancer patients are known to be at risk of chronic kidney disease. However, the standardized incidence ratio of chronic dialysis initiation did not differ significantly between cancer patients and the general population. Further studies should be performed to identify the barriers to starting renal replacement therapy in cancer patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rapport REIN (2014). http://www.agence-biomedecine.fr/IMG/pdf/rapportrein2014.pdf. (19 May 2016. Date late accessed)
Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg-Gresham JL, Feldman H, Goodkin DA, Gillespie B, Wolfe RA, Held PJ, Port FK (2004) Mortality and hospitalization in haemodialysis patients in five European countries: results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant 19(1):108–120
Stokes MB, Erazo MC, D’Agati VD (2008) Glomerular disease related to anti-VEGF therapy. Kidney Int 74(11):1487–1491
Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G; Renal Insufficiency and Cancer Medications (IRMA) Study Group (2007) On behalf of the. Prevalence of renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 110(6):1376–1384
Janus N, Launay-vacher V, Byloos E, Machiels JP, Duck L, Kerger J, Wynendaele W, Canon JL, Lybaert W, Nortier J, Deray G, Wildiers H (2010) Cancer and renal insufficiency: results of the BIRMA study. Br J Cancer 103(12):1815–1821
Kessler M, Frimat L, Panescu V, Briançon S (2003) Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l’Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year. prospective. community-based study. Am J Kid Dis 42(3):474–485
Marchand JL (2010) Generating person-years and calculating SMR using SAS: a simple program for exact calculations. Rev Epidemiol Sante Publique 58(5):370–374
Breslow NE, Day NE. Statistical methods in cancer research. Volume II- The design and analysis of cohort studies. IARC Sci Pub. 1987; (82):1–406.
Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J (2001) Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis 38(6):1178–1184
Wauters JP, Bosson JL, Forneris G, Turc-Baron C, Golshayan D, Paternoster G, Martina G, Hurot JM, von Albertini B, Forêt M, Cordonnier D, Piccoli G; Diamant Alpin Collaborative Dialysis Study Group (2004) Patient referral is influenced by dialysis centre structure in the Diamant Alpin Dialysis cohort study. Nephrol Dial Transplant 19(9):2341–2346
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R (2014) The EUROCARE-5 working group. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15(1):23–34
Thamer M, Kaufman JS, Zhang Y, Zhang Q, Cotter DJ, Bang H (2015) Predicting early death among elderly dialysis patients: development and validation of a risk score to assist shared decision making for dialysis initiation. Am J Kidney Dis 66(6):1024–1032
Floege J, Gillespie IA, Kronenberg F, Anker SD, Gioni I, Richards S, Pisoni RL, Robinson BM, Marcelli D, Froissart M, Eckardt KU; ARO Steering Committee (2015) Development and validation of a predictive mortality risk score from a European hemodialysis cohort. Kidney Int 87(5):996–1008
Van de Luijtgaarden MW, Noordzij M, van Biesen W, Couchoud C, Cancarini G, Bos WJ, Dekker FW, Gorriz JL, Iatrou C, Wanner C, Finne P, Stojceva-Taneva O, Cala S, Stel VS, Tomson C, Jager KJ (2013) Conservative care in Europe–nephrologists’ experience with the decision not to start renal replacement therapy. Nephrol Dial Transplant 28(10):2604–2612
Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV (2015) Cause-specific deaths in non-dialysis-dependent CKD. J Am Soc Nephrol 26(10):2512–2520
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
Data were extracted from registries. As required by the CNIL (number n° 03-053), patients had information on cancer registries (data collection and the possibility to use this information for epidemiologic study) at the date of cancer diagnosis.
Rights and permissions
About this article
Cite this article
Béchade, C., Dejardin, O., Bara, S. et al. Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie. J Nephrol 31, 111–118 (2018). https://doi.org/10.1007/s40620-016-0356-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-016-0356-8